Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Reference

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)
include FRENDA results (AMENDA + additional results, but less precise)

Search term:

Results 1 - 10 of 59 > >>
EC Number BRENDA No. Title Journal Volume Pages Year Organism PubMed ID
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B80763894 A dual-color fluorescent probe allows simultaneous imaging of main and papain-like proteases of SARS-CoV-2-infected cells for accurate detection and rapid inhibitor screening Angew. Chem. Int. Ed. Engl. 61 e202113617 2022 Severe acute respiratory syndrome coronavirus 2 -
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B80762892 A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease Cell Rep. 36 109754 2021 Severe acute respiratory syndrome coronavirus 2 34547223
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B80765673 A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication Proc. Natl. Acad. Sci. USA 105 16119-16124 2008 severe acute respiratory syndrome coronavirus 18852458
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B80765795 Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro Sci. Rep. 12 2145 2022 Severe acute respiratory syndrome coronavirus 2 35140265
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B80763479 An in silico molecular dynamics simulation study on the inhibitors of SARS-CoV-2 proteases (3CLpro and PLpro) to combat COVID-19 Mol. Simul. 47 1168-1184 2021 Severe acute respiratory syndrome coronavirus 2 -
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B80755740 Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Acta Pharm. Sin. B 10 766-788 2020 Severe acute respiratory syndrome coronavirus 2 32292689
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B80762789 Binding of SARS-CoV covalent non-covalent inhibitors to the SARS-CoV-2 papain-like protease and ovarian tumor domain deubiquitinases Biomolecules 11 802 2021 Severe acute respiratory syndrome coronavirus 2 34071582
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B80757319 Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV J. Enzyme Inhib. Med. Chem. 31 23-30 2016 Severe acute respiratory syndrome-related coronavirus 25683083
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B80755700 Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease ACS Infect. Dis. 6 2099-2109 2020 Severe acute respiratory syndrome coronavirus 2 32428392
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B80757248 Chemical-informatics approach to COVID-19 drug discovery Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors J. Biomol. Struct. Dyn. 2020 1-10 2020 Severe acute respiratory syndrome coronavirus 2 32568618
Results 1 - 10 of 59 > >>